Growth-differentiation factor-15, endoglin and N-terminal pro-brain natriuretic peptide induction in athletes participating in an ultramarathon foot race

Biomarkers

Volumn 14, Issue 6, 2009, Pages 418-422

  Tchou, Isabelle ^a   Margeli, Alexandra ^b   Tsironi, Maria ^c   Skenderi, Katerina ^d   Barnet, Marc ^a   Kanaka Gantenbein, Christina ^e   Papassotiriou, Ioannis ^b   Beris, Photis ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c UNIVERSITY OF PELOPONNESE   (Greece)

^d HAROKOPIO UNIVERSITY   (Greece)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Endoglin; Endothelium; Exercise; GDF 15; NT pro BNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ENDOGLIN; GROWTH DIFFERENTIATION FACTOR 15;

ARTICLE; ATHLETE; BLOOD LEVEL; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FOOT; HUMAN; MARATHON RUNNER; NORMAL HUMAN; PROTEIN INDUCTION;

ADULT; ANTIGENS, CD; ATHLETES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXERCISE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RECEPTORS, CELL SURFACE;

EID: 70849136351     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500903062976     Document Type: Article

References (17)

1. Bartzeliotou AI, Margeli AP, Tsironi M, Skenderi K, Bacoula C, Chrousos GP, Papassotiriou I. (2007). Circulating levels of adhesion molecules and markers of endothelial activation in acute inflammation induced by prolonged brisk exercise. Clin Biochem 40:765-770
2. Bourdeau A, Dumont DJ, Letarte M. (1999). A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104:1343-1351
3. Cruz-Gonzalez I, Pabón P, Rodríguez-Barbero A, Martín-Moreiras J, Pericacho M, Sánchez PL, Ramirez V, Sánchez-Ledesma M, Martín-Herrero F, Jiménez-Candil J, Maree AO, Sánchez- Rodríguez A, Martín-Luengo C, López-Novoa JM. (2008). Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction. J Cell Mol Med 12:955-961
4. Düwel A, Eleno N, Jerkic M, Arevalo M, Bolaños JP, Bernabeu C, López-Novoa JM. (2007). Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice. Tumour Biol 28:1-8.
5. Eggers KM, Kempf T, Allhoff T, Lindahl B, Wallentin L, Wollert KC. (2008). Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain. Eur Heart J 29:2327-2335
6. García-Pozo L, Miquilena-Colina ME, Lozano-Rodríguez T, García- Monzón C. (2008). Endoglin: structure, biological functions, and role in fibrogenesis. Rev Esp Enferm Dig 100:355-360
7. Goussetis E, Spiropoulos A, Tsironi M, Skenderi K, Margeli A, Graphakos S, Baltopoulos P, Papassotiriou I. (2009). Spartathlon, a 246 kilometers foot race: effects of acute inflammation induced by prolonged exercise on circulating progenitor reparative cells. Blood Cel Mol Diseas 42:294-299
8. Jerkic M, Rodríguez-Barbero A, Prieto M, Toporsian M, Pericacho M, Rivas-Elena JV, Obreo J, Wang A, Pérez-Barriocanal F, Arévalo M, Bernabéu C, Letarte M, López-Novoa JM. (2006). Reduced angiogenic responses in adult Endoglin heterozygous mice. Cardiovasc Res 69:845-854
9. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, Heineke J, Kotlarz D, Xu J, Molkentin JD, Niessen HW, Drexler H, Wollert KC. (2006). The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 98:351-360
10. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC. (2007a). Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50:1054-1060
11. Kempf T, Horn-Wichmann R, Brabant G, Peter T, Allhoff T, Klein G, Drexler H, Johnston N, Wallentin L, Wollert K. (2007b). Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin Chem 53:284-291
12. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP. (1999). Defective angiogenesis in mice lacking endoglin. Science 284:1534-1537
13. Margeli A, Skenderi K, Tsironi M, Hantzi E, Matalas A, Vrettou C, Kanavakis E, Chroussos G, Papassotiriou I. (2005). Dramatic elevations of interleukin-6 and acute-phase reactants in athletes participating in the ultradistance foot race Spartathlon: severe systemic inflammation and lipid and lipoprotein changes in protracted exercise. J Clin Endocrinol Metab 90:3914-3918
14. Scharhag J, Herrmann M, Urhausen A, Haschke M, Herrmann W, Kindermann W. (2005). Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 150:1128-1134
15. Vidotto C, Tschan H, Atamaniuk J, Pokan R, Bachl N, Muller MM. (2005). Responses of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) to competitive endurance exercise in recreational athletes. Int J Sports Med 26:645-650
16. Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD. (2006). GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98:342-350
17. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. (2000). Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209-214.